United Laboratories International Holdings Ltd (HKSE:03933) Share Price

Company Profile

Business description
United Laboratories International Holdings Ltd is mainly engaged in the research and development, production and sales of pharmaceuticals. The company operates in three segments: Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. The majority of the company's sales are generated in China, followed by Europe, India and other countries.
Contact
No. 6 Fuk Wang Street
Yuen Long Industrial Estate
New Territories
Hong Kong
HKG
T: +852 26871033
http://www.tul.com.cn
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
17,400

Recommended

Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.

Matthew Dolgin, CFA | 20 October 2025

Shares plunged over 17% after reporting disappointing results.

Angus Hewitt, CFA | 20 October 2025

Growth outlook solid, but upside more than priced in.

Shaun Ler | 19 October 2025

Index	Last price	Change	% Change
All Ordinaries	9,384.90	11.20	0.12%
CAC 40	8,206.07	31.87	0.39%
DAX 40	24,258.80	427.81	1.80%
Dow JONES (US)	46,706.58	515.97	1.12%
FTSE 100	9,403.57	49.00	0.52%
HKSE	26,286.47	427.64	1.65%
NASDAQ	22,990.54	310.57	1.37%
Nikkei 225	49,585.50	400.00	0.81%
NZX 50 Index	13,377.85	32.89	0.25%
S&P 500	6,735.13	71.12	1.07%
S&P/ASX 200	9,091.40	15.50	0.17%
SSE Composite Index	3,910.13	46.24	1.20%